Purchase Order 75N93019P01103
Award Date
9/4/19
Potential Completion Date
9/3/20
Potential Value
$189K
Federal Agency
National Institute of Allergy and Infectious Diseases
Awardee
Synthego Corporation
Ultimate Awardee
Not listed
NAICS Category
541380 - Testing Laboratories and Services
PSC Category
Q301 - Reference Laboratory Testing
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Competed under SAP
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Redwood City, CA 94063, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The Department of Health and Human Services, National Institutes of Health, National Institute of Allergy and Infectious Diseases awarded a firm fixed-price purchase order to Synthego Corporation, a self-certified small disadvantaged business, for the provision of 1 GENE EDITING RNA GUIDE. The potential value of the contract is $24,999.00, with a completion date of September 17, 2018. Synthego Corporation is a leading provider of genome engineering solutions, offering a range of gene editing...
The Department of Health and Human Services National Institutes of Health National Institute of Allergy and Infectious Diseases awarded a firm-fixed price purchase order to Synthego Corporation, a self-certified small disadvantaged business, for the delivery of 8.34 mg of synthetic guide RNA (sgRNA) for a target 2 100mer GMP-like product. The $24,999.00 contract supports the Division of Intramural Research at NIAID and is intended for use in a clinical trial for targeted correction of chronic...
This is a $25,150.00 firm fixed price purchase order contract awarded by the National Institute of Child Health and Human Development (NICHD), part of the Department of Health and Human Services, to Synthego Corporation, a small disadvantaged business manufacturer of gene editing products. The contract is for CRISPR genome engineering and related services to support biomedical research efforts across multiple NIH institutes. Synthego specializes in custom cell line development, gene...
This is a $146,665.75 firm fixed-price purchase order contract awarded by the Department of Health and Human Services (HHS) National Institutes of Health (NIH) National Institute on Drug Abuse to Synthego Corporation, a self-certified small disadvantaged business and manufacturer of goods. The contract was not set aside. Synthego, headquartered in Redwood City, California, is providing genome engineering solutions, including cell line engineering, CRISPR libraries, and other biological...
This is a $60,132.50 firm-fixed-price purchase order awarded by the National Center for Advancing Translational Sciences (NCATS), a civilian agency within the National Institutes of Health (NIH), to Synthego Corporation, a self-certified small disadvantaged business and manufacturer of gene editing products. The contract is for the provision of a Whole Human Genome Arrayed CRISPR Screening Library to support NCATS' translational science research efforts. This award is not associated with a...
The Department of Health and Human Services' National Institutes of Health National Center for Advancing Translational Sciences awarded a Firm Fixed Price Purchase Order to Synthego Corporation, a self-certified small disadvantaged business, for the delivery of KNOCKIN-SMALL, CELL CLONE, IMMORTALIZED with a potential value of $12,950.00. This order is part of Synthego's extensive portfolio of federal contracts to provide gene editing products, cell line engineering, and research support services...
The National Human Genome Research Institute (NHGRI), a civilian agency within the Department of Health and Human Services, has awarded a $86,750.00 firm fixed price purchase order to Synthego Corporation, a self-certified small disadvantaged business and manufacturer of gene editing products located in Redwood City, California. The contract is for CRISPR gene-editing of the ACVR1 and TGFBR1 genes in endometrial cancer cell lines to support NHGRI's research objectives. This contract was...
This is a $88,310 firm fixed-price purchase order awarded by the National Center for Advancing Translational Sciences (NCATS), part of the National Institutes of Health (NIH), to Synthego Corporation, a small disadvantaged business manufacturer of gene editing products. The contract is for CRISPR gene editing services to develop five different induced pluripotent stem (iPS) cell lines expressing fluorescent proteins or HiBiT tags at specific target genes. This is a non-competitive award under...
This is a federal contract award by the National Institute of Environmental Health Sciences (NIEHS), a civilian agency, to Synthego Corporation, a self-certified small disadvantaged business and manufacturer of gene editing products based in Redwood City, California. The contract is a $46,600 firm fixed-price purchase order with a completion date of November 15, 2020. The contract does not have a set-aside designation. Synthego specializes in providing genome engineering solutions, including...
This federal contract was awarded by the Department of Health and Human Services (HHS), National Institutes of Health (NIH), National Center for Advancing Translational Sciences to Synthego Corporation, a self-certified small disadvantaged business, for high-throughput screening to identify modulators of the expression of human HIF1 and HIF2. The firm fixed price purchase order, valued at $22,650.00, will support genetic research at Synthego's facilities in Redwood City, California through...